Building an outcome predictor model for diffuse large B-cell lymphoma.
暂无分享,去创建一个
Ramón Bosch | Marina Pollán | Máximo Fraga | Juan F. García | M. Piris | R. Bosch | A. Díez | L. Sánchez-Verde | F. Camacho | A. Sáez | M. Pollán | M. Fraga | M. Mollejo | A. Pérez‐Rosado | Manuela Mollejo | Miguel A Piris | M. Artiga | Ana Díez | Alberto Pérez-Rosado | Ana-Isabel Sáez | Antonio-José Sáez | María-Jesús Artiga | Francisca-Inmaculada Camacho | Juan-Fernando García | Silvia-María Rodríguez-Pinilla | Cristina Romero | Lydia Sánchez-Verde | A. Sáez | Cristina Romero | Silvia-María Rodríguez-Pinilla | S. Rodríguez-Pinilla
[1] S. Reed,et al. Deregulated cyclin E induces chromosome instability , 1999, Nature.
[2] B. Nathwani,et al. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .
[3] René Bernards,et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. , 2002, Genes & development.
[4] J C Reed,et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.
[5] B. Dörken,et al. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. , 2001, Blood.
[6] G. Pruneri,et al. Immunoreactivity for p27KIP1 and cyclin E is an independent predictor of survival in primary gastric non‐Hodgkin's lymphoma , 2001 .
[7] M. Piris,et al. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] J. Cigudosa,et al. Development of a Real-Time Reverse Transcription Polymerase Chain Reaction Assay for c-myc Expression That Allows the Identification of a Subset of c-myc+ Diffuse Large B-Cell Lymphoma , 2003, Laboratory Investigation.
[9] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[10] A. Sánchez-Aguilera,et al. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27. , 2001, The American journal of pathology.
[11] L. Staudt,et al. Clinical translation of gene expression profiling in lymphomas and leukemias. , 2002, Seminars in oncology.
[12] L. Larocca,et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. , 2001, Blood.
[13] M. Pagano,et al. Role of the F-box protein Skp2 in lymphomagenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.
[15] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[16] J. Teruya-Feldstein,et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. , 2002, Human pathology.
[17] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[18] G. Landberg,et al. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. , 1998, Blood.
[19] M. Pagano,et al. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. , 2002, The American journal of pathology.
[20] H. Koeffler,et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. , 2001, Cancer research.
[21] Lydia Sánchez,et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. , 2003, Blood.
[22] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[23] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.